| 216148 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Deep phenotypic characterization of NY-ESO TCR engineered T cells and tumor in patients with advanced myeloma |
2015-11-04 |
10.1186/2051-1426-3-s2-p295 |
Davila Eduardo, Melchiori Luca, Wong Ryan, Binder-Scholl Gwendolyn, Amado Rafael, Jakobsen Bent, Rapoport Aaron |
| 216147 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
2015-11-04 |
10.1186/2051-1426-3-s2-p129 |
Chandar Ashwin, Silk Ann W, Clark Joseph I, Daniels Gregory A, McDermott David F, Morse Michael, Wong Michael KK, Stein Mark, Mehnert Janice, Danish Shabbar, Aung Sandra, Kaufman Howard L |
| 216146 |
NEURO-ONCOLOGY |
Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma |
2015-11-04 |
10.1093/neuonc/nov181 |
Wright Karen D., Daryani Vinay M., Turner David C., Onar-Thomas Arzu, Boulos Nidal, Orr Brent A., Gilbertson Richard J., Stewart Clinton F., Gajjar Amar |
| 216145 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models |
2015-11-04 |
10.1186/2051-1426-3-s2-p351 |
Bellovin David, Wondyfraw Nebiyu, Levin Anita, DeNardo David G, Masteller Emma, Brennan Thomas |
| 216144 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell lines |
2015-11-04 |
10.1186/2051-1426-3-s2-p206 |
Chhabra Arvind |
| 216143 |
BMC RESEARCH NOTES |
Updating contextualized clinical practice guidelines on stroke rehabilitation and low back pain management using a novel assessment framework that standardizes decisions |
2015-11-04 |
10.1186/s13104-015-1588-8 |
Gambito Ephraim D. V., Gonzalez-Suarez Consuelo B., Grimmer Karen A., Valdecañas Carolina M., Dizon Janine Margarita R., Beredo Ma. Eulalia J., Zamora Marcelle Theresa G. |
| 216142 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML |
2015-11-04 |
10.1186/2051-1426-3-s2-p238 |
Petersen Christopher, Li Jian-Ming, Waller Edmund |
| 216141 |
NEURO-ONCOLOGY |
Highlights from the Literature |
2015-11-04 |
10.1093/neuonc/nov279 |
|
| 216140 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function |
2015-11-04 |
10.1186/2051-1426-3-s2-p321 |
Chu Fuliang, Neelapu Sattva S |
| 216139 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance |
2015-11-04 |
10.1186/2051-1426-3-s2-p315 |
Tähtinen Siri, Grönberg-Vähä-Koskela Susanna, Lumen Dave, Merisalo-Soikkeli Maiju, Siurala Mikko, Airaksinen Anu J, Vähä-Koskela Markus, Hemminki Akseli |
